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Background:  Sepsis is a life-threatening condition that can lead to septic shock and 
death. With over 300,000 annual cases (AHRQ, 2011) costing a staggering $1.5 billion 
(Health Care Utilization Project Brief #185), the importance of sepsis is becoming clear. 
However, some basic biological mechanisms are poorly understood. 
Study Purpose: This study investigated the relationships between select demographics, 
resting energy expenditure (REE), serum lactate, SOFA score mortality index, oxygen 
consumption [by way of measuring net oxygen consumed, (V02) and net carbon dioxide 
produced (VC02)], and sepsis.  
Specific Aims: Aims were to describe 1) patient demographics, serum lactate, SOFA 
score mortality index, sepsis diagnosis, and 02 consumption; 2) the difference in oxygen 
consumption in ICU patients with and without a diagnosis of sepsis; 3a) the relationships 
between gender, age, REE, height, weight, lactate and VO2; 3b) the relationships 
between gender, age, REE, height, weight, lactate and VCO2; and 4) the relationships 
between age, gender, height, weight, VO2, VCO2, lactate, SOFA, REE, and sepsis 
Methods: Data for this quantitative descriptive feasibility study were accessed from two 
hospital databases.  
Results: For the total cases (N = 21) mean age was 71.2 years (+/- 14.1) and mostly 
female (71.4%).  There was a difference in oxygen consumption between the two groups 
of cases (sepsis and non-sepsis) [VO2 (t 3.919, p<0.001); VCO2 (t 3.238, p<0.007)].  
Strong relationships were found between VO2 and REE (r = .540, p=0.011), and sepsis 
(η = .670, p = 0.001); between VCO2 and weight (r = .619, p = 0.003), REE (r = .669,  
p = 0.001) and sepsis (η = .608, p = 0.003); and between sepsis and V02 (η = 670, p = 
 
 
0.001), VC02  
(η = 608, p = 0.003), and lactate (η = 621, p = 0.003). 
Implications:  Nurses are at the forefront of monitoring patients with sepsis. While this 
study utilized a small sample size, significant relationships were found among a number 
of important clinical variables. Further research is needed utilizing larger samples to test 
predictive models for sepsis so that nurses can intervene to prevent the deterioration of 
these patients. 
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Overview of the Problem 
In the United States sepsis results in 146,000-381,000 deaths) and costs $23.7 
billion dollars per year (Torio & Moore, 2016). Over the years, advancements have been 
made to decrease deaths and cost. Evidence-based standard assessments and treatments 
have been ‘bundled’ together by The Centers for Medicaid and Medicare Services (CMS) 
to help hospitals improve mortality and morbidity as well as the costs of sepsis. The 
current criteria used by clinicians as part of their clinical decision-making for sepsis 
identification are well documented in the literature to be overly sensitive and under-
specific (Singer et al., 2016).  This leads to an over-identification of affected individuals, 
subjecting them to the risks of unnecessary treatment. 
Sepsis remains a significant critical issue for hospitals due to the potential for 
high mortality rates. At a critical point in the progress of sepsis, patients are unable to 
adequately saturate bodily tissues with oxygen. Oxygen consumption, if utilized as a 
clinical indicator, may provide evidence that sepsis is present and even becoming a 
serious issue. While new technologies allow for oxygen consumption to be measured for 
the purposes of determining the needs of the critically ill patient, it is unknown if having 
such a measure would contribute to the quality of clinical decision-making, nursing care, 
and the associated outcomes of that care. As nurses are held accountable for nurse 
sensitive indicators outlined by CMS, any condition that is monitored by CMS impacts 
accountability for professional practice.  Additionally, awareness of gaps in nursing 





improve practice and patient outcomes. Therefore, research on oxygen consumption as it 
may or may not be related to sepsis is warranted. 
This chapter will provide a definition of sepsis and address incidence, risk factors, 
current recommended treatments (CMS bundle), and ongoing challenges for managing 
sepsis in the critically ill patient. Additionally, the study problem statement, purpose, 
specific aims, conceptual framework and methods will be provided to introduce the 
reader to the study. This chapter will conclude with a discussion on the potential 
significance of the study. 
Background 
Sepsis 
Until 2016, sepsis was merely understood to be a systemic response to infection. 
More recently, sepsis is better understood to be a complex syndrome of a dysregulated 
host response to any numerous types of infections (Singer et al. 2016). The underlying 
pathology of sepsis and causation remains uncertain. However, an inflammatory response 
to illness is one of several hypotheses (Urden, Stacy, & Lough, 2014, p904).  
In 2001, a study was published by Dr. Emmanuel Rivers recommending Early 
Goal Directed Therapy (EGDT) for sepsis.  Early Goal Directed Therapy is guided by 
fluid resuscitation and oxygen delivery targeting goals of maintaining blood pressure and 
serum oxygenation (Rivers et al., 2001). Early Goal Directed Therapy was endorsed by 
The Society for Critical Care Medicine (SCCM) partnering with the Surviving Sepsis 
Campaign (SSC) to develop inclusion criteria for identification of an inflammatory 
response syndrome and to establish criteria to guide EGDT for sepsis treatment (Levy et 





Per the SSC, sepsis criteria include two or more of the indicators of the Systemic 
Inflammatory Response Syndrome (SIRS) in the presence of confirmed or suspected 
infection. The SIRS criteria include: 
Temperature >38C or <36C 
Heart Rate >90bpm 
Respiratory Rate >20/min 
White Blood Cell Count >12,000/ml or <4,000/ml or >10% immature bands 
Therefore, infection in the presence of the SIRS response was then known as sepsis (Bone 
et al., 1992).  
Sepsis Costs 
Costs of sepsis include loss of life as well as treatment expenditures. Despite 
recommendations for goal directed therapy, mortality remains 25%-30% and 40%-50% 
when patients present with shock (Cohen, 2015).  
Patients hospitalized for sepsis often need the highest level of care. Over half 
(51%) of sepsis cases require admission to the Intensive Care Unit (ICU) (Angus & Van 
der Poll, 2013).  Patients have multi-system involvement needing close monitoring for 
early signs of decline, and often need the support of mechanical ventilation (Angus & 
Van der Poll, 2013). This level of care is the most expensive care in the hospital, 
averaging $45,000 per case (Pfuntner, 2011).  
Risk Factors for Sepsis 
There is mixed evidence in the literature about what actually qualifies as a risk 
factor for sepsis. According to the Sepsis Alliance, age (very young and very old), 





sepsis. Additional patients at risk are those with burns, indwelling/invasive medical 
devices (e.g., dental and orthopedic prosthesis) or equipment (e.g., Foley catheters, 
central lines) (Sepsis Alliance, 2018.). However, there is no published evidence of causal 
relationships between these risk factors and sepsis.  
In a sepsis case review of the National Hospital Discharge Survey (NHDS) 
dataset it was determined that 33% of cases had respiratory infections and 32% of cases 
had genitourinary infections (Esper et al., 2006). Males more often had a respiratory 
condition versus females (p<0.01) and females more often had a genitourinary condition 
versus males (p<0.01).  
In another study, respiratory infections were present in 35% of the sepsis cases 
followed by genitourinary infection at 25% (Novosad et al., 2016). Per the Centers for 
Disease Control and Prevention (CDC), respiratory infection and genitourinary infection 
are two of the most common infections present when patients are admitted to hospital, 
suggesting an association with sepsis; however, no causal relationships have been 
determined by reviewing the literature (Hall, 2011).  
A large majority (48%-59%) of cases were reported to have gram positive 
bacteria. However, cases of sepsis have also been known to be associated with all forms 
of pathogenic microorganisms (Novosad et al., 2016).  This analysis also included the 
type of comorbid conditions associated with race; persons of non-White races with sepsis 
having more comorbid conditions such as diabetes, human immunodeficiency virus 
(HIV), chronic renal failure, and alcohol abuse. Persons of the White race with sepsis 





Actual causative factors may be numerous involving many mediating and 
moderating contributors requiring sophisticated research methods that have yet to be 
utilized in such vulnerable populations of patients. However, designing studies such as 
randomized clinical trials to prospectively test actual causative factors would be unethical 
in human subjects’ research. 
Incidence of Sepsis and Comorbities 
  The incidence of sepsis has risen dramatically since the early 1990s when the 
SCCM first began to describe the syndrome.  The incidence has been difficult to 
determine for at least two decades.  
Without a gold standard for sepsis identification, diagnosis has been provider- 
dependent. For this reason, sepsis cases are difficult to track and incidence is difficult to 
determine. Estimates of cases are derived from multiple sources, such as claims, death 
certificates, and International Classification of Diseases (ICD) codes.  
One 2006 retrospective analysis of distribution of sepsis cases was conducted 
using the National Hospital Discharge Survey (NHDS) dataset (Esper et al., 2006). Data 
captured in the dataset included demographic data, diagnostic codes (ICD) for sepsis, and 
procedural codes. The 25-year long dataset captured 12,505,082 cases of sepsis.  
The Effect of Sepsis upon Organ Systems 
 Any number of organ systems can be affected by sepsis. Particularly vulnerable 
systems include the following: respiratory, cardiovascular, central nervous, digestive, and 
genitourinary.  
Respiratory system.  In sepsis, involvement of the respiratory system pertains to 





mitochondria of the cell. Manifestations of sepsis with respiratory system involvement 
include shortness of breath and may require supplemental oxygen to maintain partial 
pressure of dissolved oxygen in the arterial circulation (Pa02).  Shortness of breath may 
progress to respiratory failure due to acute respiratory distress syndrome (ARDS), as 
evidence by bilateral infiltrates and Pa02 over fi02 (fraction of inspired oxygen) or (P/f) 
ratio, of <300 (requires arterial blood gas for evaluation). Acute respiratory distress 
syndrome can be triggered in sepsis by endovascular injury from cytokine release during 
the inflammatory process. Respiratory failure requires mechanical ventilation, guided by 
ongoing evaluation of arterial blood gas targeted at improving Pa02. Steroids are not 
shown to be of benefit when sepsis compromises the respiratory system and should be 
avoided due to the risk of immune suppression (Confalonieri, Salton, & Fabiano,  2017). 
Cardiovascular system. In sepsis, involvement of the cardiovascular system 
pertains to the heart and systemic circulation. Manifestations of cardiovascular 
involvement can include left ventricular strain and elevated troponin in the absence of 
any sign or symptom of acute coronary vascular blockage. Damage at the cellular level is 
believed to be the result of hypoperfusion (inadequate delivery of oxygen to the tissues), 
resulting in decreased functional capacity of the myocardial tissue. In some instances, 
inotropic drugs such as Dobutamine can help with cardiac output. Cardiovascular system 
involvement is generally evaluated by measurement of mean arterial pressure (MAP). A 
MAP < 70mmhg is the threshold for consideration of shock (Levy, 2003). Shock can be 
triggered in sepsis by capillary leak from low serum albumin from nutritional 
malabsorption and other causes. Management of cardiovascular compromise can include 





Central nervous system. In sepsis, involvement of the nervous system pertains to 
cerebral function due to hypoperfusion, sepsis related encephalopathy or toxic 
encephalopathy from sedating medications.  Manifestations of nervous system 
involvement could be an altered level of consciousness (assessed by Glasgow Coma 
Scale) and delirium (assessed by the Confusion Assessment Method [CAM]) or CAM-
ICU. Delirium, also known as acute confusion, is a sudden change in alertness from 
baseline with or a waxing and waning in alertness. Management for delirium in a patient 
that has sepsis would depend on severity and might include treatment of underlying 
infection, removal of Foley catheter, discontinuation of benzodiazepine medications, or 
reduction in any use of restraints (icudelirium.org). 
Digestive system. In sepsis, digestive system involvement pertains to the liver 
and the digestive tract.  Manifestations of liver involvement can include acute elevation 
of liver enzymes, known as “shock liver.” The digestive system can be affected in sepsis 
by decreased ability to absorb nutrients, as well as increased risk of gastric bleeding and 
perforation (believed to be a result of hypoperfusion). Management is aimed at fluid 
resuscitation to ensure adequate perfusion of tissues with fluids and nutrients (Gazmuri et 
al., 2017). 
Genitourinary system. In sepsis, genitourinary system involvement pertains to 
the kidneys with acute kidney injury (AKI) resulting from pre-renal azotemia or 
hypoperfusion of the kidney. Manifestations include an increase in elevated serum 
creatinine (in the absence of pre-existing renal disease) and diminishing urine output. A 
delicate balance of fluid resuscitation, in addition to the administration of loop diuretics 





there is risk of fluid volume overload with fluid resuscitation versus fluid volume 
depletion with the use of loop diuretics (Bellomo et al., 2017). 
Clinical Indicators of Sepsis 
Increasing attention is being paid to at-risk patients for a variety of high cost, high 
mortality conditions and syndromes. Sepsis is one of the “of concern” syndromes causing 
healthcare organizations to implement surveillance systems. For patients in critical care 
settings, a variety of indicators include vital signs, urinary output, and hemodynamic 
pressures. Two critically important indicators include serum lactate and the Sequential 
Organ Failure Assessment (SOFA) score. 
Serum lactate. Lactate is an important consideration in the critically ill patient 
with sepsis. Along with other signs of vital organ damage, an elevated serum lactate is 
one of the cardinal signs of tissue damage in a patient with sepsis. Therefore, an elevated 
serum lactate is often used by clinicians when determining a differential diagnosis of 
sepsis (Ganesh, Sharma Varghese, & Pillai, 2016).  
Lactate is a by-product of anaerobic metabolism. In sepsis, cells are thought to 
resort to anaerobic metabolism due to hypoperfusion of tissues, resulting in disrupted 
oxygen delivery to the tissues. Oxygen is metabolized within the cell by powerhouse 
organelles called the mitochondria. A four-step process along the electron transport chain 
within the mitochondria reduces oxygen to Adenosine Tri Phosphate (ATP) or usable 
energy.  When cells are deprived of oxygen, they convert to anaerobic metabolism, 
breaking down protein into much smaller yields of ATP, releasing lactic acid or lactate 
into the serum. As serum lactate is an acid, this process acidifies the blood, lowering the 





SOFA score. The SOFA score has been validated as a predictor of patient acuity 
and mortality risk (Raith et al., 2017). In sepsis, it is used as a proxy identifier for sepsis, 
as it can predict mortality risk. For example, a patient with a SOFA score of 7-9 has a 
mortality risk matching that of sepsis; and in the presence of infection, matching 
mortality risk to presence of infection is the most specific way to identify severe sepsis 
and sepsis shock given the state of the science (Raith et al., 2017).  As the score 
increases, mortality risk increases. For example, score of 0 represents risk of mortality of 
<10% and an extreme score of 24 would represent 100% mortality. As there is no gold 
standard diagnostic test or indicator for sepsis, the SOFA score is used in clinical 
decision-making to determine if a patient has sepsis when there is a suspected infection. 
SOFA scores have been recently tested for specificity over SIRS and qSOFA (modified 
SOFA with only three criteria), demonstrating improved specificity for prediction of 
mortality over SIRS (p< 0.001) and qSOFA (p<0.001) with validity of Area Under 
Receiver Operating Curve (AUROC) 0.753, 99% CI (0.750-0.757). Reliability statistics 
are not reported. 
Sepsis Treatment and Management  
In 2001, management of sepsis gained world attention. The algorithmic, goal-
directed recommendations from a randomized control trial were accepted as the gold 
standard for treatment by the SCCM and the SCC was born (Rivers et al., 2001). The 
recommendations were protocolized management aimed at targeted therapy for fluid 
resuscitation, blood pressure support, and oxygen delivery. Years later, the Rivers et al. 





medical center. An additional criticism was that the study’s outcomes were not compared 
to outcomes associated with usual/reasonable care (Cho, 2005).   
In 2014, a large scale 31-center randomized trial challenging the protocolized care 
was published in the New England Journal of Medicine (Angus et al., 2014). As a result, 
the SSC then adopted goal directed care, giving providers the freedom to use their best 
clinical judgment in managing sepsis, provided they were guided by evidence-based 
targets for mean arterial blood pressure, serum lactate, and time to antibiotics.  Recent 
studies now recommend delivery of antibiotics within one hour of identification of sepsis 
because it is associated with improved survival (Wallgren, Antonsson, Castren, & 
Kurland, 2016). 
Septic Shock 
 When the initial sepsis is not managed early in its course, septic shock may be the 
next critical stage. In septic shock, the patient’s circulatory system can no longer be 
maintained and treatment involves managing the mean arterial pressure (MAP) using 
vasopressors to maintain a value >65mmhg. Patients who reach this level of clinical 
deterioration meet the criteria for a diagnosis of septic shock (Lee & An, 2016). The 
insult to the circulatory system is the result of poor vascular tone or of capillary leakage 
from decreased absorption of albumin. This cascade results in hypoperfusion. 
Hypoperfusion is the cornerstone of shock, requiring resuscitation that is directed to 
restore of functionality of the tissue (Marik, 2010). As part of the resuscitation efforts, 
current guidelines recommend that patients who are unable to maintain a mean arterial 
pressure of 65-70mmhg require vasopressors to maintain blood pressure to support tissue 





Sepsis and the Patient in the ICU 
 Patients with sepsis who are admitted to the ICU have multisystem problems 
requiring intensive nursing surveillance and supportive care as well as management from 
an interdisciplinary team. When sepsis involves organ dysfunction and multiple systems 
are affected, the patient has progressed to severe sepsis (Angus & Van der Poll, 2013). 
These patients need organ support for any system involved. Patients need intubation and 
ventilation for respiratory failure, dialysis for renal failure, screening for and mitigation 
of delirium, IV bolus fluid resuscitation to address overall failure of other systems 
(hepatic, gastrointestinal, integumentary) due to hypoperfusion and inotropic infusions 
for cardiac failure (Angus & Van der Poll, 2013). 
When patients are unable to maintain a mean arterial pressure despite fluid 
volume resuscitation of 30ml/kg of a crystalloid such as normal saline, sepsis has evolved 
to septic shock and patients require IV vasopressor support (Dellinger et al., 2013). In 
addition to antibiotic therapy, sepsis patients in the ICU require prophylaxis because they 
are vulnerable to secondary infection. Additional intensive treatment is frequently needed 
for thrombosis (deep vein, pulmonary, cerebral), gastrointestinal bleeding, neuromuscular 
deconditioning and pressure ulcers. Prophylaxis includes tube feeding, anticoagulation 
therapy and peptic ulcer prophylaxis, physical therapy, and interventions aimed at 
preventing skin breakdown (e.g., frequent turns, prophylactic dressings, off-loading of 






Oxygen Consumption in the ICU Patient with Sepsis 
Oxygen consumption in the ICU patient with sepsis is a novel concept that has not 
been adopted clinically.  As mentioned in the introduction, oxygen consumption in sepsis 
has not been sufficiently studied in vivo (Kreymann et al., 1993). Oxygen consumption as 
measured for other purposes includes evaluation of metabolic need and cardiac output. 
Indirect Calorimetry 
Oxygen consumption is the clinical measure of aerobic respiration (Kreymann et 
al., 1993). Oxygen consumption can be measured clinically by way of indirect 
calorimetry.  Indirect calorimetry measures the percentage of oxygen inspired versus the 
percentage of carbon dioxide that is expired. This value is then entered in to an equation 
to determine energy expenditure (Marson, 2004). Traditionally, these measures have been 
captured in hospitalized patients to determine metabolic demand for prescribing tube 
feeding (Urden et al., 2014).  
Cardiac Output (Fick Principle) 
 In a steady state, oxygen coming in from the lungs should equal oxygen in the 
pulmonary vein (v02), which should also equal oxygen consumed (V02) during normal 
(aerobic) cellular respiration.  Measured levels of arterial 02 (a02) and mixed venous 02 
can be inputted into the following equation to determine cardiac output: CO = V02 (a02-
v02).  These measurements are obtained by way of a Swanz-Ganz pulmonary arterial 
catheter (Rhoades & Bell, 2009). 
Oxygen Consumption – Lactate Connection   
Serum lactate accumulates during hypoperfusion of tissues. Fluid resuscitation 





elimination of lactate from the serum.  However, in sepsis, lactate remains despite fluid 
resuscitation and often continues to rise (Lee & An, 2016). It is for this reason that 
elevated serum lactate serves as a differentiator for septic shock over other forms of 
shock. 
Referring to the physiological model of the Electron Transport Chain (see 
Theoretical Underpinnings below), when cells cannot consume oxygen to produce ATP, 
protein is used, resulting in the accumulation of the byproduct of anaerobic respiration, 
lactic acid. Therefore, elevated serum lactate serves as a distal proxy measure of impaired 
oxygen consumption.  
Serum lactate should be considered every time a patient triggers an alert for 
sepsis. Serum lactate should be re-evaluated within 6 hours of initiation of any treatment 
provided for sepsis (Levy et al, 2003). However, it should be reinforced that serum 
lactate, while considered a differentiator in sepsis, is a distal proxy measure for impaired 
oxygen consumption. 
Problem Statement 
Any type of shock has the potential to result in hypoperfusion. However, 
somehow, elevated serum lactate, despite adequate fluid volume resuscitation and oxygen 
delivery, cannot be overcome and therefore, remains a differentiator for all forms of 
sepsis.  
Why then, despite availability of oxygen in the resuscitated septic patient, do cells 
continue to contribute lactate from anaerobic respiration into the serum? Could it be a 





There is no gold standard for a diagnosis of sepsis. The determination of sepsis is 
a clinical decision left to the discretion of the interdisciplinary clinical team members, 
including ICU nurse clinicians. Therefore, more evidence, especially evidence that could 
serve as a potential specific biomarker for sepsis to ICU nurses, is needed to assist these 
clinicians. Evidence of cellular dysregulation in the form of oxygen consumption data 
may yield a much-needed added specific and sensitive indicator for sepsis. 
Study Purpose and Aims 
The purpose of this study was to investigate the relationships between select available 
demographics, resting energy expenditure (REE), serum lactate, SOFA score mortality index, 
oxygen consumption (by way of measuring V02 and VC02), and sepsis.  
Specific Aims 
 This study had four specific aims:  
Aim #1: Describe patient demographics, serum lactate, SOFA score mortality 
index, sepsis diagnosis, and 02 consumption. 
Aim #2: Describe the difference in oxygen consumption in ICU patients with and 
without a diagnosis of sepsis. 
Aim #3a: Describe the relationships between gender, age, REE, height, weight, 
lactate, and VO2.  
Aim #3b: Describe the relationships between gender, age, REE, height, weight, 
lactate, and VCO2.  
Aim #4: Describe the relationships between age, gender, height, weight, VO2, 





 Theoretical Underpinnings 
 The conceptual framework for the study is derived from theories in the field of 
quantum mechanics in the context of normal human cell physiology (Huether and 
McCance, 2015; Van Ness, 1969). Quantum mechanics explains a thermodynamic 
system, a system where energy can change states within a system. The electron transport 
chain is an in vivo model of a thermodynamic system.  
Quantum Mechanical Model: Second Law of Thermodynamics 
From the discipline of physics, the quantum mechanical model is applying 
mathematical principles to subatomic particles to explain energy and momentum (Ismael, 
2015). Within the quantum mechanical model, the second law of thermodynamics is 
described. The second law of thermodynamics concerns transfer of energy within a 
system, for example, an engine (Van Ness, 1969, p52).  In an engine, heat is applied to a 
fuel source, creating a force that drives movement forward.  Mitochondria, within the 
cell, are another example of a thermodynamic system. Energy is not lost within the 
boundary of the mitochondria, it is only converted to useable energy in the form of ATP. 
Normal Human Cell Physiology: The Electron Transport Chain  
Normal aerobic cellular metabolism, needed to sustain life, yields energy in the 
form of ATP from reduction of oxygen along the electron transport chain within the 
mitochondria (Rhoades & Bell, 2009, p320). Reduction of oxygen occurs along four 
points within the electron transport chain, with diminishing energy potential over time 
toward inertia, or in this case, natural death of the cell. The model of the electron 





is converted to energy to drive cellular processes. Figure 1 demonstrates the down 
regulation of energy potential over time, in normal human aerobic cellular metabolism. 
 
Figure 1. The Electron Transport Chain 
 
 
The overall purpose of many pharmaceuticals is to interfere with damaged processes 
along the electronic transport chain caused by genetic mutations, diseases and injuries. 
Study Research Conceptual Framework 
 The study research conceptual framework demonstrates the relationship between 














Figure 2. Conceptual Framework 
 
Serum Lactate and Sepsis 
 Measurement of serum lactate, as a marker for hypoperfusion in sepsis, has been 
driving sepsis identification since Emmanuel Rivers first recommended Early Goal 
Directed Therapy (EGDT) in 2001 (Rivers et al., 2001).  Per the International Sepsis 
Definition Conference of 2001, serum lactate of >3.0 mmol/L is indicative of 
hypoperfusion in sepsis (Levy et al, 2003).  Since the launch of EGDT, the sepsis 
management apparatus had hinged on the notion that elevated serum lactate in sepsis is 
due to hypoperfusion, or impaired delivery of oxygen (Rivers et al., 2001). 
Around the same time that EGDT was published, an alternative hypothesis was 
recommended by Dr. Mitchell Fink; that elevated serum lactate, as well as elevated 
venous oxygen, was in fact, due to mitochondrial dysfunction rather than impaired 
delivery of oxygen (Fink, 2001).  Fink coined the term cytopathic hypoxia to describe the 













cytopathic hypoxia, and only subscribing to hypoperfusion as an explanation for elevated 
lactate, was a dangerous path to take. However, his recommendation never gained any 
traction, and EGDT remained the gold standard for sepsis care (Dellinger et al., 2012).  
Dr. Fink was part of the University of Pittsburgh team who published in 2014 that EGDT 
had no benefit over usual care (Angus et al,, 2014).  Unfortunately, Dr Fink died in 2015 
and was unable to investigate oxygen cytopathic hypoxia as it might be related to sepsis.  
Oxygen Consumption and Sepsis 
 As mentioned above, elevated serum lactate can represent impaired delivery of 
oxygen. However, it can also represent impaired intracellular consumption of oxygen.  As 
a result of a shift to anaerobic metabolism, elevated serum lactate can occur due to 
unavailability of oxygen or due to the inability to convert available oxygen into useful 
energy.  A study published in 1993 demonstrated clinically significant (p< 0.001) 
differences in oxygen consumption were observed between mechanically ventilated 
patients with sepsis, sepsis syndrome, septic shock, and healthy adults (Kreymann et al., 
1993). In this study, oxygen consumption was compromised in the sepsis syndrome and 
in septic shock patients compared to the healthy adults (metabolic norms) (p<0.001).  
Study weaknesses included 1) no validity or reliability statistics reported for the 
instruments; 2) the monitor used was simply described as a “pragmatic oxygen sensor 
and infrared C02 sensor”; and 3) definitions and stratifications of sepsis have changed 
since 1993, making it extremely difficult to apply this evidence today. Because there is 
limited research investigating the relationship between oxygen consumption and sepsis, it 





Energy Expenditure and Sepsis 
 Energy expenditure (REE), or resting metabolic rate, is calculated from oxygen 
consumption (V02) and carbon dioxide production (VC02) in aerobic respiration. The 
Weir equation is used to determine metabolic need. This is called indirect calorimetry and 
is usually calculated to determine the rate of tube feeding required for the critically ill 
(Urden et al., 2014). The Weir equation is as follows:  EE kcal/day = 3.941 x V02(L/min) 
+ 1.11 x VC02(L/min) x 1440 (Stapel et al., 2015). 
 Since calculation of REE is dependent on measures of oxygen consumption, a 
difference in oxygen consumption will therefore influence a difference in REE. Thus, if a 
significant difference in oxygen consumption exists in a patient with sepsis compared to a 
patient without sepsis, a significant difference in REE would exist in that patient with 
sepsis compared to a patient without sepsis. Thus, REE may be an important variable in 
determining the odds of a patient having sepsis.   
SOFA Score and Sepsis 
 In 2002, a manuscript was published comparing the Acute Physiology and 
Chronic Health Evaluation (APACHE II) score against the Multiple Organ Dysfunction 
Score (MODS) and the Sequential Organ Failure Assessment (SOFA) score for 
prediction of mortality in critical illness (Bota, Melot, Ferreira, Ba, & Vincent, 2002).  
No significant difference in the performance of the measures in predicting sepsis 
was found for patients who did not present with shock compared to patients who did 
present with shock. For patients who did present with shock, SOFA was found to be most 





0.750 was significantly different compared to MODS of 0.694 (between means difference 
p<0.01). The AUROC for APACHE II was not reported.  
 When the new definition of sepsis was published in 2016, the consensus 
recommendation for improved sepsis identification was to use the SOFA score to identify 
patients at risk for sepsis (Singer et al., 2016).  Investigators conducting a retrospective 
analysis using the University of Pittsburgh dataset for patients with suspected infection 
determined that the AUROC for SOFA in predicting mortality was 0.74 compared to the 
SIRS of 0.64, within a between means difference of p<0.001.  This group stated that the 
traditional focus on inflammation and the SIRS response was “misleading” and lacked 
specificity for sepsis. SOFA was recommended for improved specificity, specifically in 
ICU patients.  
 Most recently, findings from a large-scale study (184,875 patients at 182 ICUs 
across New Zealand and Australia) substantiated the use of the SOFA score to predict 
mortality in patients with suspected infection who are admitted to the ICU (Raith et al., 
2017). This study was also a retrospective database analysis. The AUROC for SOFA at 
0.753 was significantly different when compared to the SIRS AUROC (0.589) with a 
between means difference of p<0.001.  
 Without a gold standard to identify sepsis, clinicians remain dependent on the 
SOFA mortality index scores for identification of patients at risk for sepsis. A patient 
with a SOFA score of 8 (20%) to 12 (50%) has a mortality index matching that of a 
diagnosis of sepsis (Raith et al., 2017). Pertaining to the examples above, SOFA has been 





APACHE II and MODS. Based on this evidence it will be important to measure the 
relationship between the SOFA score and sepsis. 
Summary 
 This chapter has introduced the condition of sepsis with background pertaining to 
the pathophysiology and history of sepsis management. A case for the study has been 
presented. Chapter 2 will offer a systematic review of the literature to investigate what is 













In the 25 years since the original “SEP-1” definition of sepsis in 1992, many 
patients have died, many lives have been significantly altered, and many resources have 
been spent while the mortality from sepsis continues to rise. The cost to patients and 
families in terms of loss and disability are immeasurable. In addition, there is an 
environmental cost to consider. The downstream effects of decades of empiric, broad 
spectrum antibiotic use include increasing rates of bacterial resistance and alterations to 
the human microbiome. Costs to healthcare resources are also considerable. Under the 
Value Based Purchasing plan, the Centers for Medicare & Medicaid Services (CMS) 
have enlisted the Hospital Engagement Networks to assist with monitoring of patient 
safety indicators. The Agency for Healthcare Research & Quality (AHRQ) reports on 
healthcare delivery costs captured by the Healthcare Cost and Utilization Project 
(HCUP). Their 2014 report, (HCUP brief #185), described the average cost of treating 
sepsis in hospital in 2011 as $45,500 per case, with a total number of cases at 304,367. 
That is a cost of $1.5 billion annually on sepsis care (Barrett, Smith, Elixhauser, 
Honigman, & Pines, 2014). 
In October of 2015, CMS launched a campaign to optimize the current state of 
sepsis care in the United States. As the entity entrusted to monitor quality and ensure 
patient safety with a goal of reducing mortality, CMS will eventually mandate hospitals 
to report the incidence of sepsis, as well as measures for sepsis management. Mandatory 





endorsed by the Surviving Sepsis Campaign; patients must have two or more of the 
following signs in the presence of confirmed or suspected infection: 
 Temperature >38C or <36C 
 Heart Rate >90bpm 
 Respiratory Rate >20/min 
 White Blood Cell Count >12,000/ml or <4,000/ml or >10% immature bands 
Reporting was expected to be mandatory by fiscal year 2018, however that target 
date has been delayed and remains to be determined. Many hospitals are finding these 
inclusion criteria, based on the Systemic Inflammatory Response Syndrome (SIRS) 
model, overly sensitive in identifying patients (Graham, Krall, Presente, Saucier, & 
Butler, 2016).  As the SIRS model is an adaptive model, these criteria can be present in 
adaptive states, such as multiple forms of stress, anxiety, pain, or milder illness.  
 In February 2016, a new definition of sepsis, “SEP-3,” was introduced. This new 
definition described sepsis for the first time as a “dysregulated” host response to infection 
(Singer et al., 2016). The nature of the dysregulated response is yet to be declared. 
Understanding the dysregulated nature of sepsis offers an opportunity to yield criteria for 
identification that have increased specificity for sepsis over SIRS.  
Mitochondrial Dysfunction in Sepsis 
Mitochondrial dysfunction in sepsis has been tested in the laboratory setting; 
however, its role in sepsis is still unclear. The discovery of a clear relationship between 
mitochondrial dysfunction and sepsis could potentially provide new information to 
inform the new definition of sepsis as a dysregulated response. For the purposes of this 





consumption along the electron transport chain. Mitochondrial dysfunction has been 
studied in human cells at the level of laboratory science and is now being tested in animal 
studies. No clinical evidence exists in the literature to demonstrate what mitochondrial 
dysfunction in sepsis would look like as a clinical, in vivo manifestation of the disease. 
The purpose of this paper is to examine the existing scientific evidence regarding the 
relationship between mitochondrial dysfunction and sepsis. 
Entropy and Aerobic Respiration 
Mitochondria are intracellular organelles responsible for aerobic metabolism or 
the production of energy in the form of adenosine triphosphate (ATP). The mitochondria 
are a thermodynamic system and thus subjected to the second law of thermodynamics. 
The second law of thermodynamics states that the irreversible natural degradation of 
matter occurs over time. This concept is referred to as entropy (Van Ness, 1969). 
Mitochondria are exquisitely designed to create useable energy within the boundary of its 
system. Energy is not lost in the process, but it is transformed within the system. The 
mitochondrial system is considered an open system, as it can exchange matter and energy 
across its boundaries. Thus, mitochondria are subject to entropy (disorder and 
dysfunction over time) as the system proceeds through its lifespan toward an irreversible, 
natural death.  
Sepsis Management 
Although strides have been made since sepsis was first defined in 1992 as the 
SIRS response to infection, sepsis remains a leading cause of death with a mortality rate 
of 30% (Bone et al., 1992; Vincent, Martin, & Levy, 2016). Goals of sepsis management 





therapy (Seymour & Rosengart, 2015). Treatment recommendations have not changed 
significantly since 2001 when the Surviving Sepsis Campaign (SSC) championed Early 
Goal Directed Therapy (Rivers et al., 2001). These recommendations were tested by a 
National Institute of Health (NIH) funded study which challenged the recommendations 
and published no difference in outcomes when measured against usual care (Angus et al., 
2014).  However, one could argue that “usual care” has regressed to mean targets that the 
SSC has championed and endorsed.  
Cytopathic Hypoxia and the Electron Transport Chain 
The electron transport chain within the mitochondria creates useable energy for 
the organism in the form of ATP in normal, aerobic cellular respiration. The process of 
ATP synthesis consists of four complexes. Each complex represents an area for necessary 
sequential enzymatic cytochrome oxidase activity. Potential for disruption of these 
normal enzymatic processes occurs when nitric oxide (NO) reacts with ROS creating 
peroxynitrite (ONOO-), leading to further downregulation of normal mitochondrial 
respiration. This disruption leads to conversion to anaerobic respiration, resulting in 
accumulation of excess serum lactate in the septic host.   
The phenomenon of mitochondrial dysfunction in sepsis was first coined by Dr. 
Mitchell Fink in 2002, as a process he named “cytopathic hypoxia” (Fink, 2002).  Fink’s 
description of cytopathic hypoxia is a process in which enzymatic reactions along the 
electron transport chain are disrupted in the presence of nitrous oxide (NO). NO is a 
substrate produced when cells are exposed in vitro to lipopolysaccharide endotoxin 
(LPS), a laboratory proxy for bacterial infection. This early process is a reversible 





into ONOO- yields when NO comingles with the reactive oxygen species (ROS), 
superoxide (02-). Once ONOO- production occurs, disruption is irreversible (incapable 
of recovery). As 02- is generated by NO disruption of enzymatic processes along the 
electron transport chain, it is only a matter of time before ONOO- is produced and 
mitochondrial dysfunction becomes irreversible (entropic), resulting in cell death. 
Materials and Methods 
Healthcare literature databases were searched for the review using key terms to 
elicit relevant literature on mitochondrial dysfunction in sepsis. Articles retrieved were 
evaluated for inclusion/exclusion (see Study Selection below). A subsequent search was 
done using terminology derived from themes in the retrieved articles. 
Key Terms 
 The initial search was conducted using the terms sepsis, mitochondrial 
dysfunction, and cytopathic hypoxia. The initial review of the literature identified 
nicotinamide adenine dinucleotide (NAD) as a consistent theme in cytopathic hypoxia. 
As NAD is also a key term in Fink’s conceptualization of cytopathic hypoxia, it was 
added to the mix of terms for a subsequent search. 
Data Sources  
Articles were retrieved from databases PubMed and CINAHL (Cumulative Index 
of Nursing and Allied Health Literature). The selection process is demonstrated in Table 






Table 1.   
Selection of Articles for Review 
Database/Search 
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Studies of human subjects or human cells, after 2001, full text, available in 
English from peer reviewed journals, original experimental, quasi experimental, or cohort 
studies only. Studies examining the relationship between mitochondrial dysfunction in 
sepsis, using a combination of keywords to serve as search terms (sepsis + mitochondrial 





cytopathic hypoxia, sepsis + mitochondrial dysfunction + NAD). After deselecting for 
duplicates, animal studies, non-English text, editorials, reviews of the literature, and those 
predating 2001, of the 99 articles retrieved, only 10 were selected to meet criteria for 
study selection.  
Data Extraction and Risk of Bias Assessment 
 Searches were done solely by the author to eliminate risks to inter-rater reliability. 
Some variability in instrumentation exists between the studies included in the analysis 
and where consistent instrumentation may have been used in more than one study, 
measurements were independent of each other. 
 Techniques for culture and inoculation of cells of subjects demonstrate 
consistency as cells were either from individuals with a diagnosis of sepsis, or cells 
inoculated with lipopolysaccharide (LPS) gram-negative endotoxin.  
Description of Included Studies 
  Characteristics of the included studies are listed in Table 2. All studies were 
conducted on human cells. Four studies used cells from human patients infected with 
sepsis or septic shock (platelets, peripheral blood mononuclear cells, skeletal muscle 
cells, plasma). Six studies were conducted on commercially available human cells 
(endothelial cells, hepatoma cells, human dermal fibroblasts, renal tube epithelial cells, 
umbilical vein endothelial cells, colon carcinoma cells). Six studies were laboratory 
experimental, two were prospective observational, one cohort, one quasi-experimental. 
Of the laboratory studies, four used a lipopolysaccharide endotoxin as a proxy for sepsis, 
one used cytomix (a commercially available mixture of cytokines), and one used serum 





pharmacologic intervention to investigate reversibility of mitochondrial dysfunction in 
sepsis. 
Table 2.  
Articles Included in Review 
Study Country Setting Study Design Study 
Population 
Instrumentation Findings 
Protti et al. 
(2015). 
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Common Instrumentation Used 
 Instruments used for measurement of substrates include spectrophotometry (three 
studies), high resolution respirometry (three studies), polarography (three studies), 
fluorimetry (three studies), Western blot assay (two studies), flow cytometry (two 
studies). Additionally, multiple other assays were used to identify substrates along the 







  Studies were evaluated to identify themes for analysis. Many differing 
instruments were used in the studies, and a high degree of variability exists between the 
substrates measured within the 10 studies included in the review. This illustrates a gap in 
the current literature for consistency in measurement.  
 Table 3 demonstrates the most frequently used instruments identified in the 
review, grouped against the most frequently observed substrates. Elements of 
mitochondrial function including electron transport chain activity, ATP yield, and 
mitochondrial membrane potential were measured as common themes within the studies 
reviewed. Fluorimetry, Polarography, & Spectrophotometry yielded the most frequent 
observations. Table 2 demonstrates p values of substrates measured (see Findings, Table 
2). Of the substrates observed along the electron transport chain, 19 significant p-values 
were identified for substrates of respiratory chain activity measured by 
spectrophotometry. The substrates measured included cytochrome c oxidase, NADH-
dehydrogenase, ATP hydrolase, & hydrogen peroxide. The matrix demonstrated the most 






Table 3.  




 These p-values were then entered in to Statistical Package for the Social Sciences 
(SPSS) software for descriptive modeling. P-values for respiratory chain activity of cells 
cultured in either sepsis serum of LPS endotoxin versus control were not normally 
distributed, rejecting the null hypothesis and therefore, offering evidence of 
mitochondrial dysfunction in sepsis consistently among the test cases. 
Discussion 
Time is Toxin. The articles reviewed in this investigation map out a complex 
picture of mitochondrial disruption in the presence of sepsis, especially in the context of a 
gram negative LPS endotoxin. The disruption is dynamic, stimulating the production of 
reactive nitrogen species (RNS) in the form of nitric oxide (NO), causing eventual, 
irreversible disruption of multiple complexes along the electron transport chain by 
inhibiting cytochrome oxidase, resulting in decreased ATP synthesis. However, an earlier 





(eventual production of ONOO-) only occurs when high levels of NO are generated, and 
reversibility is possible if the process is interrupted before NO rises above a sub-
molecular threshold. Current therapies aimed at fluid resuscitation and oxygen delivery 
have not demonstrated to have any capacity to halt or reverse this process. As the cascade 
is triggered by the infecting sepsis-causing agent, the bleak analogy of an accelerated 
process of entropy in the presence of an LPS endotoxin underscores the urgency of early 
antibiotic intervention, that is, if there is any hope of reversibility of inhibition of 
cytochrome oxidase.  
Time is toxin, and time to antibiotics, should be given the same urgency as “time 
is muscle” or “time is brain,” the colloquialisms used to encourage fibrinolytic therapy 
for an acute stroke, or percutaneous intervention for acute myocardial infarction. A study 
by Wallgren et al. (2016) investigated mortality associated with antibiotic delay in 61 
patients presenting to the Emergency Department with overt sepsis versus covert sepsis. 
Their findings demonstrated mortality risk associated with time delay to antibiotics. 
Delays beyond the first hour dropped survival to 20%. The 2016 SSC consensus 
guidelines recommended administration of antibiotic therapy within one hour after 
identification of sepsis or septic shock (Rhodes et al., 2017). This was given a “strong 
recommendation, moderate quality of evidence” under the Grading of Recommendations 
Assessment, Development, and Evaluation (GRADE) system, suggesting that the highest 
quality of evidence existed to correlate antibiotics within one hour to survival.  
Conclusion 
The articles included in the review demonstrated consistent, statistically 





however remains weak as there is no consistent thread of instrumentation and measured 
substrate within the base of evidence. As the pooled results for spectrophotometry 
suggests rejecting the null hypothesis, further investigation is warranted. As the current 
state of this evidence is limited to laboratory investigation, it remains to be tested in vivo 
to determine clinical significance for mitochondrial dysfunction as a manifestation of 
disease in sepsis. In the meantime, our best weapon against sepsis is to protect host cells 
















This investigation was a retrospective database descriptive study and utilized a 
hospital evidence-based practice (EBP) project database and an electronic health record 
(EHR) database. The primary dataset was previously developed for the purpose of 
collecting metabolic data under an evidenced-based practice model. The original clinical 
data had been collected comprehensively at discrete patient encounters, once per patient 
during their stay, for the purpose of determining metabolic need and tube feeling 
formula/rate.  
Potential Significance of Proposed Study 
Improving on the specificity and sensitivity for sepsis identification can only 
improve each hospital’s CMS bundle compliance, appropriateness of care, allocation of 
resources, and result in the best possible patient outcomes.  The addition of oxygen 
consumption and possibly other independent variables identified in this study may inform 
a growing list of more appropriate criteria used for clinical decision-making in the 
identification of sepsis among ICU patients.  Addressing this gap has the potential to shift 
the course of sepsis management for the first time in 25 years. 
Statement of Purpose  
The purpose of this study was to investigate the relationships between select available 
demographics, resting energy expenditure (REE), serum lactate, SOFA score mortality index, 
oxygen consumption (by way of measuring V02 and VC02), and sepsis. The cases for this study 





Study Aims  
This study had four specific aims:  
Aim #1: Describe patient demographics, serum lactate, SOFA score mortality index, 
sepsis diagnosis, and 02 consumption. 
Aim #2: Describe the difference in oxygen consumption in ICU patients with and 
without a diagnosis of sepsis. 
Aim #3a: Describe the relationships between gender, age, REE, height, weight, 
lactate, and VO2.  
Aim #3b: Describe the relationships between gender, age, REE, height, weight, 
lactate and VCO2.  
Aim #4: Describe the relationships between age, gender, height, weight, VO2, VCO2, 
lactate, SOFA, REE, and sepsis. 
Setting 
Cases included were from a 12-bed medical ICU within a small community 
hospital (<150 beds) in Southern California. The population served by this community 
hospital includes many community members from multiple local skilled nursing facilities 
that are within close proximity to the hospital. Many patients admitted to this ICU are 
elderly and frail and are admitted for exacerbations of chronic illness, influenza, 
healthcare associated conditions (pneumonia, urinary tract infection), and sepsis. Per 
City-Data.com (2018), the ethnic groups within this community are White 63.3%, 
Hispanic 18.3%, Asian 11.6%, Black 1.4%, and American Indian 0.5%. The community 







Patients admitted from June to December 2017 were selected as cases. All case 
data were extracted from an EBP project database.  
Inclusion criteria: All patients included in the original EBP project were included 
as cases in this research study. Specifically, these were patients in the ICU intubated for 
mechanical ventilation who were anticipated to require tube feeding. 
Exclusion criteria: Only cases in the original EBP project were included in this 
research study; there were no exclusion criteria for this research study. However, it 
should be highlighted that ICU patients who were ventilated but not identified as 
requiring tube feeding (e.g., NPO status, comfort care) would not have been in the 
original EBP database; therefore, they were not included in this research study. 
Study Variable Operational Definitions and Measures 
Demographics. Age, weight, and gender were abstracted from the EHR. Age and 
weight were included because they each can have an effect upon metabolic demand. Two 
options for gender were available: male or female. 
Serum Lactate. Serum lactate values are typically used by physicians to 
determine a differential diagnosis of sepsis. Serum lactate guides fluid volume 
resuscitation and repeat lactate values are used to inform the provider of patient’s 
responsiveness to treatment. Serum lactate is also considered a current differentiator for 
septic shock over other types of shock. Serum lactate values were abstracted from the 
EHR as a continuous numeric value.  
Sepsis versus Non-Sepsis. There is no gold standard for the diagnosis of sepsis. 





discretion of the physicians. Sepsis diagnosis data were abstracted from the EHR and 
options included yes or no.  
SOFA Score. The Sepsis-related Organ Failure Assessment (SOFA) is a 
mortality index score (range 0-24) and is a calculated number based on six clinical 
criteria (Glasgow Coma Scale, Platelets, Mean Arterial Pressure, Serum Creatinine, total 
bilirubin, and Partial Pressure of Arterial Oxygen over Fraction of Inspired Oxygen or 
P/F ratio). Patient specific values for these criteria are assigned a final score based on the 
criteria.  The SOFA score has gained acceptance as the most specific metric for sepsis.  
The SOFA Index score was calculated by the investigator per standardized 
instructions that are based on abstraction of the six clinical criteria from the medical 
record and plotted against the “calculator” or value index table (Table 4). A higher score 
is interpreted as an increased risk of mortality. 
Table 4.  
SOFA score mortality risk index criteria 
 
Oxygen Consumption. Oxygen consumption is the conversion of inspired 
oxygen (02) to Adenine Tri-Phosphate, or ATP, where carbon dioxide is a by-product of 





MetaphorTM metabolic monitor by attaching it to the ventilator circuit to evaluate 
metabolic demand and was used clinically for the purpose of determining tube feeding 
requirements. Oxygen consumption was calculated by analysis of gases on inspiration 
against the net gains/losses of gases on expiration.  Oxygen consumption data in the form 
of VO2 and VCO2 (measures discussed below) were abstracted from an evidence-based 
practice project database.  
Table 5.  
Study Variables 
Variable Operational Definition Instrumentation/Data 
Sources 
Measures 
Demographics Age, Gender, Weight EHR Age in years, Gender (M/F), 
Weight in kg 
Lactate Serum lactate 
(lactate dehydrogenase 
protein in blood) 
Electronic Health Record 
(EHR) 
Laboratory value for serum lactate 
in mmol/L 
02 Consumption Net pp O2 inspired & 
net pp C02 expired 
Metabolic Monitor V02 & VCO2 values in mmHg 
REE Resting energy 
expenditure  
Calculated using EHR 
data & Weir Equation 
Weir Equation:  
Metabolic rate (kcal per day) = 
1.44 (3.94 VO2 + 1.11 VCO2)  
SOFA Severity 
Score 
Mortality index (0-24) 
based on 6 criteria 
Calculated using EHR 
data & SOFA Score 
Calculator 
  
SOFA Score Calculator: Calculated 
based on 6 criteria (assessment and 
lab data) at admission and 48 hours 
Sepsis Diagnosis Clinical diagnosis of 
sepsis as determined by 
MD 







 While no instrumentation was expressly used to collect data for this study, 
instruments were used previously in the clinical setting to obtain the original patient 
assessment data for the EBP project.  
Metabolic Monitor. The metabolic monitor used for the earlier EBP project was 
a MetaphorTM unit developed by TreyMed (Milwaukee, WI). The device is non-invasive 
and attaches to the ventilator circuit in a similar way that standard end tidal C02 
monitoring devices attach to ventilators. The MetaphorTM unit is easily attached and 
removed from a ventilator.  No published data exists on reliability for the MetaphorTM.  
Oxygen consumption is the gold standard for determination of metabolic need in 
the critically ill patient and globally represented as a Respiratory Quotient (RQ).  RQ = 
VCO2 eliminated/VO2 consumed. Raw scores can range from 1.0-0.7.  Raw scores are 
acceptable for reporting, provided the measurement device has passed internal calibration 
testing. Mean scores are calculated by summing scores and dividing by number of cases. 
For the purposes of this study the two portions of global oxygen consumption are 
utilized separately: VO2 (oxygen consumption) and VCO2 (carbon dioxide production). 
Each is reported as a range: 0.1 to 1,000ml/min e Accuracy: 2 ml/min plus 7%.  
 Weir Equation. The Weir equation is the gold standard equation for determining 
resting energy expenditure (REE). The calculation of Metabolic rate (kcal per day) = 1.44 
(3.94 VO2 + 1.11 VCO2) guides recommendations for metabolic requirements for 






Table 6.  
Instrumentation 




FDA 510(k) pre-market 
cleared device. Device 
captures many components 
r/t oxygenation and 
metabolism. This device 
will capture 02 consumption 
and EE.  
VO2 Oxygen consumption 
VCO2 Carbon dioxide 
production Range: 0.1 to 
1000ml/min e Accuracy: 2 
ml/min plus 7% 
No published data 
Lab Analysis of 
Serum Lactate 
“Siemens Vista” Laboratory 
Platform for in-vitro 
diagnostics 
Serum lactate correlation 
coefficient for Siemens 
Vista 0.998, R 122 
Mean precision 
repeatability of 





The SOFA score, is the 
gold-standard predictive 
sepsis mortality index 
endorsed by the Society of 
Critical Care Medicine  
Improved specificity for 
prediction of mortality over 
SIRS (p< 0.001) and 
qSOFA (p<0.001) AUROC 
0.753, 99% CI(0.750-
0.757) 
Cronbach’s alpha for 
SIRS and qSOFA 
(α=0.57), for qSOFA 
and SOFA (α=0.28) 
and SIRS compared 
to SOFA (α=0.06) 
Weir Equation 
(1949) 
Gold Standard equation for 
determining resting energy 
expenditure (REE) and 
metabolic need; Metabolic 
rate (kcal per day) = 1.44 
(3.94 VO2 + 1.11 VCO2). 
No published data CI 95% 
 
Sample Size Calculation 
 G-Power sample size calculation yields a desired sample size of 602 using an 
alpha of .05 and a beta of .20.  
Protection of Human Subjects 
This study was conducted with oversight from two Institutional Review Boards 





Data Acquisition Plan 
After obtaining IRB study oversight, data were extracted from EBP project 
database for metabolic measurements and the ERH. Data were then deidentified and 
entered into an Excel spreadsheet and finally entered into SPSS version 23 for statistical 
analysis. 
Data Analysis Plan 
 To address Aim #1, means and standard deviations were used to describe age, 
weight, oxygen consumption, and serum lactate and frequencies were conducted for 
gender, SOFA, and sepsis diagnosis.  To address Aim #2, an independent t test was used 
to compare the difference in oxygen consumption in ICU patients with and without a 
diagnosis of sepsis. Aims 3a, 3b, and 4 were addressed using Pearson r correlations and 
Etas. To obtain p values for the Eta statistics, ANOVAs were utilized. 
 Summary 
 This study examined oxygen consumption in cases with and without a diagnosis 
of sepsis. Other variables such as lactate, demographics, and SOFA score were analyzed 










The purpose of this study was to investigate the relationships between select 
available demographics, resting energy expenditure (REE), serum lactate, SOFA score 
mortality index, oxygen consumption (by way of measuring V02 and VC02), and sepsis. 
The cases for this study were identified via an ICU ventilated patients tube feeding EBP 
project metabolic database.   
This chapter will present the results the study including case characteristics. 
Results will be presented in order of the identified aims of the study. Of the 21 cases, 
none had missing data. 
Study Aim #1 
Describe patient demographics, serum lactate, SOFA score mortality index, sepsis 
diagnosis, and 02 consumption. 
To address aim #1, means, standard deviations and distributions for continuous 
data were conducted. For categorical data, percentages were calculated.  
Study sample size was 21 cases. Mean age was 71.2 years (SD 14.1), height 64.4 
inches (SD 3.7), and weight 171.3 pounds (SD 51.1). The majority of the sample was 
female (n=15, 71.4%). Clinical data included a mean SOFA score of 5.2 (SD 2.2), mean 
lactate of 2.8 mmol/L (SD 2.5), and mean Resting Energy Expenditure (REE) of 1,823.4 
kcal/day (SD 685.6). Sepsis diagnosis for the entire sample was 52.4% (n = 11).   
Next, to further characterize the sample, the descriptive data was compared by 
sepsis groups (sepsis versus non-sepsis) (see Table 7 for specifics). There were no 





height, and weight) or SOFA scores.  Serum lactate was significantly different between 
the two groups with the sepsis diagnosis group having higher serum lactate levels (t -
3.456 p<0.004). VO2 and VCO2 will be discussed in Aim #2 results. 
Table 7.  
Case Characteristics by Sepsis Diagnosis  




Age in years, mean (SD) 71.2 (14.1) 73.8 (11.1) 68.4 (17.0) .393 
Female, no. (%) 15 (71.4) 7 (63.6) 8 (80.0) .997  
Height in inches, mean (SD) 64.4 (3.7) 63.0 (3.6) 65.9 (3.8) .068 
Weight in lbs, mean (SD) 171.3 (51.1) 161.7 (53.3) 181.8 (49.0) .381 
SOFA 5.2 (2.2) 4.3 (1.9) 6.0 (2.1) .070 
V02 in mmHg, mean (SD) 37.8 (11.2) 30.9 (8.3) 45.5 (8.8) .001 
VC02 in mmHg, mean (SD) 34.3 (6.6) 30.5 (3.4) 38.4 (7.0) .007 
Lactate in mmol/L, mean (SD) 2.8 (2.5) 4.2 (2.8) 1.2 (0.3) .004 
REE in kcal/day, mean (SD) 1823.4 (685.6) 1582.9 (475.1) 2087.9 (803.3) .092 
 
Study Aim #2:  
Describe the difference in oxygen consumption in ICU patients with and without 
a diagnosis of sepsis. 
To address aim #2, an independent t-test was used to compare the two groups. 
There was a statistically significant difference in oxygen consumption between the two 
groups of cases (sepsis and non-sepsis) for VO2 (t 3.919, p<0.001) and for VCO2 (t 
3.238, p<0.007). The VO2 and the VCO2 were higher in the non-sepsis group. The t-test 
results are presented in Table 7. 
Study Aim #3a 
Describe the relationships between gender, age, REE, height, weight, serum lactate, 
and VO2.  
To address study aim # 3a, a Pearson’s r Correlation was conducted for the 





There were strong positive relationships between V02 and sepsis (η = 670, p<.001) and 
REE (r = .540, p<.011), respectively.  
Table 8.  









Study Aim #3b 
Describe the relationships between gender, age, REE, height, weight, lactate, and 
VCO2.  
To address study aim #3b, a Pearson r Correlation was conducted for the continuous 
level variables and an Eta was conducted for the categorical level variables (See Table 9). 
There were strong relationships between VC02 and sepsis (η = .608, p<.003), REE  






Age r = .018 .939 
Gender η = .092 .692 
Height r =.369 .100 
Weight r= .332 .142 
REE r = .540 .011* 
Lactate r = -.329 .145 





Table 9.  










Study Aim #4 
Describe the relationships between age, gender, height, weight, VO2, VCO2, 
lactate, SOFA, REE, and sepsis. 
To address aim #4a, chi square and Eta statistics were used to determine the 
relationships between the independent variables and the dependent variable (sepsis). 
There were strong relationships between sepsis and gender (η = 0.687, p = 0.407), V02 (η 







Age r = -.275 .229 
Gender η =  .108 .642 
Height r =.299 .188 
Weight r= .619 .003* 
REE r = .669 .001* 
Lactate r = -.258 .258 





Table 10.  







Gender 0.6871 0.407 
Age 0.1972 0.393 
Height 0.406 0.068 
Weight 0.202 0.381 
V02 0.670 0.001 
VC02 0.608 0.003 
Lactate 0.621 0.003 
SOFA 0.403 0.070 
REE 0.377 0.092 
 Note: 1 Chi square, 2 Eta 
 
Study Limitations 
This study had a smaller than required G power sample size of 602. The sample 
was dependent on the number of patients in an available EBP project database. 
Additional study limitations are discussed in chapters four and five.  
Summary 
 This study examined oxygen consumption in critically patients using hospital data 
bases as the source of data. Differences were discovered between those with and without 
a diagnosis. Strong relationships were found between important clinical variables and 







Discussion of Findings 
The purpose of this study was to investigate the relationships between select 
available demographics, resting energy expenditure (REE), serum lactate, SOFA score 
mortality index, oxygen consumption (by way of measuring V02 and VC02), and sepsis. 
The cases for this study were identified via a metabolic dataset that had been developed 
for a tube feeding EBP project. 
This chapter will present a summary of the findings, limitations, and strengths of 
this study.  Implications for nursing practice will also be presented.  
 This study had four specific aims. Each were to describe 1) patient demographics, 
serum lactate, SOFA score mortality index, sepsis diagnosis, and 02 consumption; 2) the 
difference in oxygen consumption in ICU patients with and without a diagnosis of sepsis; 
3a) the relationships between gender, age, REE, height, weight, lactate, and VO2; 3b) the 
relationships between gender, age, REE, height, weight, lactate, and VCO2; the 
relationships between age, gender, height, weight, VO2, VCO2, lactate, SOFA, REE, and 
sepsis. 
Summary of Study Findings 
Case Demographic Characteristics 
 The study cases had a mean age of 71.2 (SD 14.1) years with more females  
(n = 15, 71.4%) compared to males. Mean height 64.4 inches (SD 3.7), and weight 171.3 
pounds (SD 51.1). The mean age and gender split are reflective of the surrounding 





differences in age or gender between cases in this sample with a diagnosis of sepsis 
compared to those without. 
Case Clinical Characteristics 
 Clinical variables for this study included measures of oxygen consumption (V02, 
VC02), resting energy expenditure (REE), serum lactate, mortality index (SOFA score), 
and sepsis. Sepsis diagnosis for the entire sample was 52.4% (n = 11). Specific results for 
V02, CO2, and REE clinical variables are available in chapter four. Of interest here is the 
mean scores for V02, CO2, and REE for those cases with a diagnosis of sepsis were 
significantly lower when compared to those without. Clinically, this possibly could be 
interpreted as meaning that despite available oxygen and adequate tissue perfusion, 
normal metabolism is altered in sepsis, perhaps reflecting mitochondrial injury. However, 
there are no known cutoff scores and/or ranges or standards established for evaluating 
oxygen consumption (V02, VC02) or REE in sepsis. This information among patients 
with sepsis in an ICU represents a novel study finding and warrants further research.  
The mean serum lactate level for cases with a diagnosis of sepsis was higher 
(mean 4.2mmol/L; SD 2.8) and significantly different from those without a diagnosis of 
sepsis (mean 1.2mmol/L; SD 0.3). Using the 2016 Clinical Practice Guideline from the 
Surviving Sepsis Campaign (SSC) a patient would be considered ruled in as suspicious 
for sepsis for any value greater than 2mmol/L. The mean score for cases in this study 
with a diagnosis of sepsis attained that threshold, therefore it was important that cases 
were examined by sepsis diagnosis versus no sepsis diagnosis.  
The SOFA score is used to predict mortality among ICU patients. The mean 





with a diagnosis of sepsis compared to those without. A SOFA score of 5.2 reflects a low 
mortality index of approximately 15% (Raith et al., 2017). This is lower overall than the 
mortality risks associated with sepsis-induced septic shock, which are between 25% and 
50% (Cohen, 2015). Therefore, for the total cases in this study were at low risk for death. 
The mean SOFA score for the sepsis group was 4.3(SD 1.9), and for the non-sepsis 
patients 6.0 (SD 2.1). The difference is not significant (p=0.070), however, it is an 
interesting finding as a higher score is generally expected to be associated with a 
diagnosis of sepsis.  
Sepsis and Oxygen Consumption 
For this study, two measures of oxygen consumption were examined separately, 
VO2 and VCO2. For VO2. As stated previously, there have been no prior studies to offer 
clinical findings for oxygen consumption in sepsis, making these clinical findings unique 
in the field of sepsis.  
Strong positive relationships between V02 and sepsis (η = .670, p<.001) and REE 
(r = .540, p<.011), respectively, were identified, and strong relationships between VC02 
and sepsis (η = .608, p<.003), REE (r = .669, p<.001), and weight (r = .619, p<.003) 
respectively. Strong relationships were also identified between sepsis and gender (η = 
0.687, p = 0.407), V02 (η = 0.670, p = 0.001), VC02 (η = 0.608, p = 0.003), and lactate 
(η = 0.621, p = 0.003). 
More research is needed examining these potentially important study findings. 
Limitations of the Study 
Study limitations are common when using a secondary dataset for analysis. A 





The data for this study were extracted from the EBP project database and EHRs. 
Therefore, the data had not been collected for the purpose of prospectively investigating 
the difference in oxygen consumption between sepsis versus non-sepsis patients. This 
limited the amount of cases as well as the number of variables. Had a prospective study 
been conducted, additional variables would have included ethnicity, socioeconomic 
status, mean arterial pressure (MAP), and suspected sources of infection and the timeline 
for data collection would have been extended to obtain the calculated sample size (N = 
602).  
Additionally, a selection bias may have been present in this study. The data were 
originally collected to determine the nutritional needs of patients admitted to the ICU 
who were being considered for tube feedings. Therefore, potential cases where tube 
feeding was contraindicated (e.g., nutritionally stable, NPO status, comfort care status) 
were eliminated from this study. It is recommended that inclusion criteria for future 
studies include a broader range of nutritional status among the ICU patients. 
Finally, all reported results for which inferential statistics determined the findings 
in this study should be viewed with caution due to the small sample size (N = 21). This 
study statistically was underpowered.  
Study Strengths 
Many studies utilizing clinical data are cost prohibitive to conduct. This study 
incurred no such costs because the data were already available. While this study was 
completed with a small sample size, there were considerably large effect sizes 
demonstrated. Therefore, this investigation has the potential to contribute to the design of 





Cooper, & Lancaster, 2010). Finally, this is the first study to examine oxygen 
consumption in patients with sepsis and therefore, makes a significant first step in 
understanding important clinical relationships that may eventually lead to predictive 
models to prevent and manage sepsis in critically ill patients. 
Study Implications 
 Sepsis can be especially difficult to prevent in patients, especially older adults. 
Sepsis represents a significant management challenge for healthcare professionals, 
because it often leads to septic shock and death among their patients. Nurses are 
positioned on the frontline level to prevent and/or to be alert for signs of sepsis. 
Additionally, they may offer opportunities to slow the decline of sepsis into deadly cases 
of septic shock when the appropriate types of clinical data are available (Schorr, 2016). 
As this study pertains to clinical observations of indicators in sepsis, it draws a particular 
appeal to nursing practice and research. Study implications will be discussed here, 
including opportunities for nursing practice and nursing research.  
Nursing Practice 
Nurses have the opportunity to champion themselves as experts in clinical 
surveillance. Objective clinical measures such as vital signs, lab values, wave form 
tracings, and pressure readings that are captured daily during clinical monitoring may be 
utilized as triggers of clinical deterioration, thus providing opportunities to intervene. 
Surveillance differs from monitoring in that it utilizes data in a systematic way that is 






While this study utilized a small sample, it represents the first step that may 
eventually offer a predictive model for sepsis that employs one or more variables 
representing oxygen consumption, novel variables. Oxygen consumption currently is 
easy to measure; it is already being utilized to determine the metabolic needs of ICU 
patients. Practically, nurses could use falling measures of oxygen consumption to 
intervene and prevent untoward clinical outcomes such as further deterioration of patients 
with sepsis.  
Nursing Research 
 A number of subsequent research studies can be recommended to continue this 
study’s line of inquiry.  These include further expansion of the study to include more 
variables that are often included in other sepsis studies (mean arterial pressure, time to 
first antibiotic, survival to discharge) and other variables that might contribute to a 
phenotype model (ethnicity, immunologic profiling, and other biomarkers). Alternately, a 
larger scale prospective study or secondary analysis of existing larger metabolic-type 
databases may offer the opportunity for improved statistical power and the generation of 
a meaningful predictive model for sepsis.  
 There have been no earlier studies identifying measures of oxygen consumption 
as a significant biomarker for sepsis. Such a specific biomarker for sepsis would be a 
prudent next step. A larger scale analysis could identify a sensitive intercept where 
oxygen consumption starts to trend down even prior to the major signs of infection. This 






The purpose of this study was to investigate the relationship between oxygen 
consumption and sepsis. Secondary databases were accessed for the purpose of 
conducting the study statistical analysis. Utilizing these secondary databases came with 
certain limitations. However, the study findings did identify a statistically significant 
difference in measures of oxygen consumption (VO2 and VCO2) in sepsis cases when 
compared to non-sepsis cases as well as some important clinical variables that were 
related to VO2, VCO2 and sepsis.   
Conclusion 
The mortality risk for sepsis remains high, 25% - 50% (Seymour & Rosengart, 
2016). Per the Healthcare Cost and Utilization Project (HCUP) report, the average cost of 
treating one case of sepsis in the hospital is $45,500 amounting to $1.5 billion annually 
being spent on sepsis care (Barrett et al., 2014). 
There is no gold standard for the diagnosis of sepsis. The determination of sepsis 
is a clinical decision left to the discretion of the interdisciplinary clinical team members, 
including ICU nurse clinicians and physicians. In 2016, the Third International 
Consensus definition of sepsis was published (Singer et al., 2016). This definition 
rejected the 25-year-old notion of the SIRS response and offered that sepsis was a 
“dysregulated” host response to infection. No operational definition has been offered to 
explain the dysregulated nature of this host response to infection. Evidence of cellular 
dysregulation in the form of oxygen consumption may yield a much-needed added 
specific and sensitive biomarker for sepsis. This study has contributed some of the first 
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